Stefania Cowser
Family · Cullman, ALNPI 1598477705
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $673, 3.7 times the $181 reported in 2023.
Across 61 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$166
- AstraZeneca$143
- Otsuka America Pharmaceutical, Inc.$105
- Lilly USA, LLC$103
- Exact Sciences$66
- Axsome Therapeutics, Inc.$60
- plus $557 from 17 others
What the payments were for
- Food & beverage$1,199100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 8 | $166 |
| AstraZeneca | 8 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Lilly USA, LLC | 5 | $103 |
| Exact Sciences | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| AbbVie | 3 | $58 |
| Jazz Pharmaceuticals Inc. | 2 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Amgen | 3 | $41 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Bayer | 2 | $40 |
| Merck | 2 | $37 |
| Dexcom, Inc. | 2 | $36 |
| Harmony Biosciences LLC | 1 | $34 |
| Intra-sana Laboratories | 2 | $32 |
| Medtronic | 2 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Seqirus USA Inc | 1 | $24 |
| Insulet Corporation | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
How this compares
$1,199 in reported general payments places this provider in the 65th percentile of 3,415 family providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 15 | $10,125 |
| Methylprednisolone | 27 | $210 |
| Fluticasone Propionate | 17 | $190 |
| Ciprofloxacin Hcl | 12 | $65 |
| Prednisone | 13 | $25 |
Paid to pharmacies, not to this prescriber.
Other family in Cullman
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
- Julia BettsHuntsville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.